RELAPSING REMITTING MULTIPLE SCLEROSIS

This study is testing if a stem cell transplant can better control multiple sclerosis (MS) than the strongest available drugs in people whose MS stays active despite treatment. The transplant involves wiping out a person's faulty immune system with chemotherapy and then rebuildin…

This study is testing whether a small implanted device that stimulates a nerve in the neck can help repair the protective coating (myelin) on nerves in people with relapsing-remitting multiple sclerosis (RRMS). The device is surgically placed and delivers a minute of stimulation …

This study aims to find out if an older, less expensive drug called rituximab works just as well as a newer, much more expensive drug called ocrelizumab for controlling relapsing multiple sclerosis (MS). About 386 adults with active relapsing MS will be randomly assigned to recei…

This early-stage study is checking if a drug called ixazomib, used for a type of blood cancer, is safe for people with multiple sclerosis (MS). The goal is to see if it can reduce harmful antibodies linked to MS in the fluid around the brain and spine. About 72 participants with …

This study is testing whether two specific diet plans, followed by a period of calorie restriction for weight loss, can improve daily life for people with multiple sclerosis. One hundred adults with MS will follow either a low-glycemic or standard diet for 32 weeks, with free gro…

This study aims to understand why certain MS treatments work for a long time. Researchers will observe 100 people with relapsing-remitting MS who are already taking specific B-cell therapies. They will collect detailed blood samples and track symptoms over several years to learn …

This study is testing whether a new digital platform helps doctors monitor people with multiple sclerosis (MS) more effectively. The platform includes an AI tool that analyzes brain scans and a patient app for tracking symptoms and medications. Researchers will enroll 500 people …